Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (The Mayo Clinic Experience)

American Journal of Cardiology

Volumn 88, Issue 10, 2001, Pages 1091-1096

  Singh, Mandeep ^a   Berger, Peter B ^a   Ting, Henry H ^a   Rihal, Charanjit S ^a   Wilson, Stephanie H ^a   Lennon, Ryan J ^a   Reeder, Guy S ^a   Bresnahan, John F ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DEATH; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; Q WAVE; RISK FACTOR; STATISTICAL ANALYSIS; THROMBUS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 0035889483     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02040-9     Document Type: Article

References (17)

1. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
2. Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart; Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
3. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up
4. Intracoronary thrombus: Still a risk factor for PTCA failure?
5. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: A quantitative angiographic analysis
6. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
7. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
8. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
9. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
10. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient
11. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial
12. Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions
13. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: In-hospital and 30-day results of the PAMI stent pilot trial
14. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions
15. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology
16. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 pilot) trial
17. Angioscopic versus angiographic detection of thrombus during coronary interventional procedures